<DOC>
	<DOCNO>NCT01926457</DOCNO>
	<brief_summary>The investigator plan study sample woman prediabetes ( diagnose Hemoglobin A1c ( HbA1c ) 5.7-6.4 % fast plasma glucose ( FPG ) 92-125 mg/dL ) first trim pregnancy , patient randomize first trimester third trimester treatment ; first trimester group receive intervention immediately upon diagnosis prediabetes whereas third trimester group receive routine prenatal care 28 week time receive intervention . Intervention define : - diabetes education - blood glucose monitoring - medication need - growth ultrasounds - antenatal test The primary outcome umbilical cord C-Peptide &gt; 90th percentile . Secondary outcome include neonatal fat mass delivery , infant weight-for-length 12 month age , maternal gestational weight gain , biomarkers ( chemical ) measure placenta baby 's umbilical cord blood . The investigator hypothesize woman undergo intervention first trimester deliver significantly few neonate umbilical cord C-Peptide &gt; 90th percentile , neonates low fat mass , weight-for-length 12 month . The investigator hypothesize great proportion patient undergo first trimester intervention appropriate maternal gestational weight gain define Institute Medicine , great proportion return prepregnancy weight within 12 month .</brief_summary>
	<brief_title>Treating Prediabetes First Trimester</brief_title>
	<detailed_description>The primary aim propose research demonstrate promote normoglycemic intrauterine milieu woman prediabetes diagnose first trim pregnancy Hemoglobin A1c ( HbA1c ) 5.7-6.4 % fast plasma glucose ( FPG ) 92-125 mg/dL decrease accumulation fetal white adipose tissue development infant/child obesity first year life . This project build upon hypothesis pregnant subject prediabetes randomize first trim pregnancy strict glycemic control pharmacotherapy need less fetal adiposity adverse neonatal outcome receive diagnosis prediabetes initiate care third trimester . In proposed study , 240 woman meet criterion prediabetes â‰¤ 15w0d gestation randomize either first trimester third trimester treatment . Each group diabetes education , initiate blood glucose monitoring , begin pharmacotherapy need ( per establish protocol ) , undergo growth ultrasound , antenatal testing . The first trimester arm receive intervention immediately upon diagnosis prediabetes whereas third trimester arm receive routine prenatal care 28 week time begin education treatment . Both group treat identically 28 week delivery . In 2013 National Institutes Health ( NIH ) Gestational Diabetes ( GDM ) Consensus Conference , panel concern adopt criterion would increase prevalence GDM ( i.e . first trimester treatment ) without first demonstrate improve outcome . The result propose trial , allow u fill key research gap ; first prospective trial evaluate International Associations Diabetes Pregnancy Study Groups ( IADPSG ) recommendation screen diagnose prediabetes first trimester . Findings research quantify maternal neonatal benefit harm treat woman prediabetes early pregnancy . Additionally , cohort neonate result study follow childhood evaluate whether first trimester treatment benefit beyond anticipated birth may decrease long-term incidence obesity diabetes .</detailed_description>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Pregnant woman age 18 Any ethnic background English Spanishspeaking Planned prenatal care/delivery The University California , San Diego 's Hillcrest Hospital Singleton pregnancy Prediabetes diagnose prior 15w0d HbA1c 5.76.4 % FPG 92125 mg/dL Known Type 2 Diabetes ( T2DM ) T2DM diagnose first trim screen Patients know maternal/fetal indication delivery &lt; 36w0d Patients present care 15w0d</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>First trimester treatment prediabetes</keyword>
	<keyword>First trimester treatment gestational diabetes</keyword>
	<keyword>Umbilical cord C-Peptide</keyword>
	<keyword>Neonatal fat mass</keyword>
	<keyword>Gestational weight gain</keyword>
	<keyword>Infant obesity</keyword>
</DOC>